Mary W. Walker

4.1k total citations · 1 hit paper
38 papers, 3.5k citations indexed

About

Mary W. Walker is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Mary W. Walker has authored 38 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 33 papers in Cellular and Molecular Neuroscience and 6 papers in Surgery. Recurrent topics in Mary W. Walker's work include Neuropeptides and Animal Physiology (31 papers), Receptor Mechanisms and Signaling (29 papers) and Chemical Synthesis and Analysis (7 papers). Mary W. Walker is often cited by papers focused on Neuropeptides and Animal Physiology (31 papers), Receptor Mechanisms and Signaling (29 papers) and Chemical Synthesis and Analysis (7 papers). Mary W. Walker collaborates with scholars based in United States, Denmark and Switzerland. Mary W. Walker's co-authors include Theresa A. Branchek, Christophe Gerald, Kelli E. Smith, Richard L. Weinshank, Jonathan Bard, Pierre J.‐J. Vaysse, Margaret M. Durkin, Eric L. Gustafson, David L. Linemeyer and Leoluca Criscione and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Mary W. Walker

38 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A receptor subtype involved in neuropeptide-Y-induced food intake

1996 771 citations Christophe Gerald, Mary W. Walker et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary W. Walker United States	26	2.9k	2.2k	1.0k	508	458	38	3.5k
Serge St‐Pierre Canada	31	2.3k 0.8×	1.8k 0.8×	467 0.5×	301 0.6×	414 0.9×	98	2.9k
V. Mutt Sweden	18	1.9k 0.7×	1.1k 0.5×	524 0.5×	433 0.9×	289 0.6×	43	2.4k
Philippe Brabet France	29	1.3k 0.4×	1.8k 0.8×	427 0.4×	311 0.6×	191 0.4×	65	3.3k
Dieter Meyer Germany	31	2.0k 0.7×	1.7k 0.8×	346 0.3×	238 0.5×	206 0.4×	115	3.2k
Roberta Possenti Italy	29	1.1k 0.4×	1.1k 0.5×	524 0.5×	277 0.5×	191 0.4×	65	2.6k
M. Marcinkiewicz Canada	25	1.1k 0.4×	1.3k 0.6×	212 0.2×	394 0.8×	119 0.3×	58	2.7k
Steven L. Sabol United States	29	1.6k 0.5×	2.0k 0.9×	232 0.2×	254 0.5×	151 0.3×	41	3.1k
E Herbert United States	22	1.3k 0.5×	1.4k 0.6×	619 0.6×	121 0.2×	252 0.6×	33	2.7k
E.M. Lutz United Kingdom	23	1.6k 0.6×	1.3k 0.6×	198 0.2×	318 0.6×	341 0.7×	45	2.1k
Patricia Joseph‐Bravo Mexico	29	857 0.3×	534 0.2×	560 0.6×	99 0.2×	457 1.0×	114	2.3k

Countries citing papers authored by Mary W. Walker

Since Specialization

Citations

This map shows the geographic impact of Mary W. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary W. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary W. Walker more than expected).

Fields of papers citing papers by Mary W. Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary W. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary W. Walker. The network helps show where Mary W. Walker may publish in the future.

Co-authorship network of co-authors of Mary W. Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Mary W. Walker. A scholar is included among the top collaborators of Mary W. Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary W. Walker. Mary W. Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Lingyun, Kai Lǚ, Mathivanan Packiarajan, et al.. (2012). Indolyl and dihydroindolyl N-glycinamides as potent and in vivo active NPY5 antagonists. Bioorganic & Medicinal Chemistry Letters. 22(6). 2167–2171. 5 indexed citations

Packiarajan, Mathivanan, Heather Coate, Emily J. Reinhard, et al.. (2011). 5-(2′-Pyridyl)-2-aminothiazoles: Alkyl amino sulfonamides and sulfamides as potent NPY5 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(21). 6500–6504. 12 indexed citations

Wu, Lingyun, Kai Lǚ, Mathivanan Packiarajan, et al.. (2011). N-Heteroaryl glycinamides and glycinamines as potent NPY5 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(18). 5573–5576. 5 indexed citations

Parker, Michael S., Renu Sah, Trevor W. Sweatman, et al.. (2010). Maintenance of Y receptor dimers in epithelial cells depends on interaction with G-protein heterotrimers. Amino Acids. 40(2). 371–380. 7 indexed citations

Walker, Mary W., Toni D. Wolinsky, Vrej Jubian, et al.. (2008). The Novel Neuropeptide Y Y5 Receptor Antagonist Lu AA33810 [N-[[trans-4-[(4,5-Dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]-methanesulfonamide] Exerts Anxiolytic- and Antidepressant-Like Effects in Rat Models of Stress Sensitivity. Journal of Pharmacology and Experimental Therapeutics. 328(3). 900–911. 49 indexed citations

Walker, Mary W., Kenneth Jones, Joseph A. Tamm, et al.. (2005). Use of Caenorhabditis elegans Gαq Chimeras to Detect G-Protein-Coupled Receptor Signals. SLAS DISCOVERY. 10(2). 127–136. 3 indexed citations

Islam, Imadul, John Finn, Ping Du, et al.. (2002). Discovery of potent and selective small molecule NPY Y5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 12(13). 1767–1769. 16 indexed citations

Durkin, Margaret M., Mary W. Walker, Kelli E. Smith, et al.. (2000). Expression of a Novel Neuropeptide Y Receptor Subtype Involved in Food Intake: An in Situ Hybridization Study of Y5 mRNA Distribution in Rat Brain. Experimental Neurology. 165(1). 90–100. 50 indexed citations

Branchek, Theresa A., Kelli E. Smith, Christophe Gerald, & Mary W. Walker. (2000). Galanin receptor subtypes. Trends in Pharmacological Sciences. 21(3). 109–117. 415 indexed citations

10.

Borowsky, Beth, Mary W. Walker, Kenneth Jones, et al.. (1998). Cloning and characterization of the human galanin GALR2 receptor. Peptides. 19(10). 1771–1781. 47 indexed citations

11.

Borowsky, Beth, Mary W. Walker, Jonathan Bard, et al.. (1998). Molecular biology and pharmacology of multiple NPY Y5 receptor species homologs. Regulatory Peptides. 75-76. 45–53. 41 indexed citations

12.

Criscione, Leoluca, Pascal Rigollier, Christine Batzl‐Hartmann, et al.. (1998). Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor.. Journal of Clinical Investigation. 102(12). 2136–2145. 183 indexed citations

13.

Smith, Kelli E., Mary W. Walker, Roman Artymyshyn, et al.. (1998). Cloned Human and Rat Galanin GALR3 Receptors. Journal of Biological Chemistry. 273(36). 23321–23326. 222 indexed citations

14.

McCarthy, J. Brian, Mary W. Walker, Joseph P. Pierce, Patricia Camp, & Jeffrey D. White. (1998). Biosynthesis and Metabolism of Native and Oxidized Neuropeptide Y in the Hippocampal Mossy Fiber System. Journal of Neurochemistry. 70(5). 1950–1963. 28 indexed citations

15.

Walker, Mary W., Kelli E. Smith, Jonathan Bard, et al.. (1997). A Structure-Activity Analysis of the Cloned Rat and Human Y4 Receptors for Pancreatic Polypeptide. Peptides. 18(4). 609–612. 33 indexed citations

16.

Du, Ping, John Salon, Joseph A. Tamm, et al.. (1997). Modeling the G-protein-coupled neuropeptide Y Y1 receptor agonist and antagonist binding sites. Protein Engineering Design and Selection. 10(2). 109–117. 48 indexed citations

17.

Gerald, Christophe, Mary W. Walker, Leoluca Criscione, et al.. (1996). A receptor subtype involved in neuropeptide-Y-induced food intake. Nature. 382(6587). 168–171. 771 indexed citations breakdown →

18.

Bard, Jonathan, Mary W. Walker, Theresa A. Branchek, & Richard L. Weinshank. (1995). Cloning and Functional Expression of a Human Y4 Subtype Receptor for Pancreatic Polypeptide, Neuropeptide Y, and Peptide YY. Journal of Biological Chemistry. 270(45). 26762–26765. 323 indexed citations

19.

Jazin, Elena, Anders Blomqvist, Frances Yee, et al.. (1993). A proposed bovine neuropeptide Y (NPY) receptor cDNA clone, or its human homologue, confers neither NPY binding sites nor NPY responsiveness on transfected cells. Regulatory Peptides. 47(3). 247–258. 75 indexed citations

20.

Miller, R. J., Douglas A. Ewald, Aaron P. Fox, et al.. (1988). The Effect of Calcium Channel Antagonists on Peripheral Neurones^a. Annals of the New York Academy of Sciences. 522(1). 269–277. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact